Clover Health Investments Long Term Debt 2020-2025 | CLOV

Clover Health Investments long term debt from 2020 to 2025. Long term debt can be defined as the sum of all long term debt fields.
Clover Health Investments Annual Long Term Debt
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $20
2020 $106
2019 $0
Clover Health Investments Quarterly Long Term Debt
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30 $20
2022-06-30 $20
2022-03-31 $20
2021-12-31 $20
2021-09-30 $20
2021-06-30 $20
2021-03-31 $24
2020-12-31 $106
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.537B $1.371B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.768B 58.23
Hims & Hers Health (HIMS) United States $14.374B 149.35
Tempus AI (TEM) United States $11.826B 0.00
IRhythm Technologies (IRTC) United States $4.653B 0.00
Inspire Medical Systems (INSP) United States $3.861B 60.33
Hinge Health (HNGE) United States $3.282B 0.00
Privia Health (PRVA) United States $2.664B 182.08
Enovis (ENOV) United States $1.720B 9.59
Phreesia (PHR) United States $1.560B 0.00
Schrodinger (SDGR) United States $1.501B 0.00
Azenta (AZTA) United States $1.357B 63.06
10x Genomics (TXG) United States $1.331B 0.00
Omnicell (OMCL) United States $1.313B 23.17
Claritev (CTEV) United States $0.657B 0.00
Fulgent Genetics (FLGT) United States $0.595B 0.00
Butterfly Network (BFLY) United States $0.514B 0.00
Veradigm (MDRX) United States $0.487B 0.00
Talkspace (TALK) United States $0.448B 134.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.337B 746.67
Outset Medical (OM) United States $0.336B 0.00
Nyxoah SA (NYXH) Belgium $0.263B 0.00
Health Catalyst (HCAT) United States $0.251B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.156B 0.00
EUDA Health Holdings (EUDA) Singapore $0.138B 0.00
CareCloud (CCLD) United States $0.106B 4.03
Pulmonx (LUNG) United States $0.105B 0.00
American Well (AMWL) United States $0.105B 0.00
MDxHealth SA (MDXH) Belgium $0.094B 0.00
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.051B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.046B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
Zhongchao (ZCMD) China $0.037B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00